The Business Research Company’s Precision Cancer Imaging Market Report 2026 – Market Size, Trends, And Global Forecast 2026-2035
LONDON, GREATER LONDON, UNITED KINGDOM, July 6, 2026 /EINPresswire.com/ — “The field of precision cancer imaging has seen remarkable advancements recently, playing a vital role in improving cancer diagnosis and treatment. As technology evolves and cancer rates continue to rise, this market is set for substantial growth driven by innovations and increasing demand for personalized healthcare solutions. Below is an in-depth look at the market’s size, growth factors, regional dynamics, and emerging trends shaping its future.
Forecasted Growth and Market Size of the Precision Cancer Imaging Market
The precision cancer imaging market has experienced significant expansion in recent years. It is projected to grow from $17.39 billion in 2025 to $19.58 billion in 2026, representing a compound annual growth rate (CAGR) of 12.6%. This historical growth is largely fueled by the rising number of cancer cases worldwide, advancements in molecular imaging technologies, greater adoption of PET and MRI systems, enhanced diagnostic infrastructure in hospitals, and expanding government-backed cancer screening programs.
Download a free sample of the precision cancer imaging market report:
https://www.thebusinessresearchcompany.com/sample_request?id=25235913&type=smp&utm_source=EINPresswire&utm_medium=Paid&utm_campaign=Jun_PR
Looking ahead, the market is expected to accelerate further, reaching an estimated $31.71 billion by 2030 with a CAGR of 12.8%. The forecast period’s growth is supported by increased demand for personalized oncology treatments, broader adoption of AI-powered imaging analytics, heightened investments in precision medicine research, the rise of cloud-based imaging platforms, and the development of less invasive diagnostic techniques. Key trends anticipated to influence the market include wider use of precision oncology imaging, integration of hybrid imaging systems, adoption of multi-modal diagnostic workflows, advances in radiomics for tumor characterization, and improvements in early cancer detection technologies.
Understanding Precision Cancer Imaging and Its Role
Precision cancer imaging represents a sophisticated medical imaging approach that combines highly targeted and accurate techniques to detect, characterize, and monitor cancer at its earliest stages. This approach integrates various modalities—including molecular imaging, functional imaging, and high-resolution anatomical imaging—to enhance diagnostic accuracy and support personalized treatment planning tailored to individual patients.
View the full precision cancer imaging market report:
https://www.thebusinessresearchcompany.com/report/precision-cancer-imaging-market-report?utm_source=EINPresswire&utm_medium=Paid&utm_campaign=Jun_PR
Key Drivers Behind the Expansion of the Precision Cancer Imaging Market
A primary factor driving market growth is the increasing prevalence of cancer globally. This rise is largely linked to an aging population, as older individuals face a higher risk of developing cancer due to the accumulation of genetic mutations and prolonged exposure to environmental risk factors over time. Precision cancer imaging plays a crucial role in cancer management by enabling earlier detection, precise tumor localization, and customized treatment strategies that improve patient outcomes while reducing unnecessary procedures.
To illustrate the scale of this challenge, in February 2024, the World Health Organization—a Switzerland-based authority on global health policy—reported projections of over 35 million new cancer cases by 2050. This represents a 77% increase compared to about 20 million cases recorded in 2022. Such an expected surge in cancer cases further underscores the importance of precision imaging techniques and fuels the ongoing demand within this market.
Regional Insights and Market Leadership in Precision Cancer Imaging
North America held the largest share of the precision cancer imaging market in 2025, reflecting the region’s advanced healthcare infrastructure and widespread adoption of cutting-edge technologies. Conversely, the Asia-Pacific region is forecast to exhibit the fastest growth over the coming years, driven by expanding healthcare investments, increasing cancer incidence, and growing awareness of advanced diagnostic methods.
The market report encompasses a wide range of regions, including Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, and the Middle East and Africa, providing a comprehensive perspective on global trends and opportunities in precision cancer imaging.
Our 2026 market reports now include enhanced strategic insights through:
• Market attractiveness scoring and analysis
• Total addressable market (TAM) analysis
• Company scoring matrix graphics and tables
• Excel-based forecasting dashboards
• Market hotspots infographics
• Key technologies and future trend analysis
• Updated graphics and tables
Speak With Our Expert:
Saumya Sahay
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email: marketing@tbrc.info
The Business Research Company – www.thebusinessresearchcompany.com
Follow Us On:
• LinkedIn: https://in.linkedin.com/company/the-business-research-company“
Oliver Guirdham
The Business Research Company
+44 7882 955267
info@tbrc.info
Visit us on social media:
LinkedIn
Facebook
X
Legal Disclaimer:
EIN Presswire provides this news content “as is” without warranty of any kind. We do not accept any responsibility or liability
for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this
article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
Media gallery
